Cargando…

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma

Herpesvirus entry mediator (HVEM) displays dual signals in T-cell activation according to the ligands and intracytoplasmic effectors it interacts with. High HVEM expression may play an immunosuppressive role in several malignancies. The present study investigated the clinical impact of HVEM on intra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Bingqi, Meng, Huijuan, Tian, Ye, Wang, Yingying, Song, Tianqiang, Zhang, Ti, Wu, Qiang, Cui, Yunlong, Li, Huikai, Zhang, Wei, Li, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716701/ https://www.ncbi.nlm.nih.gov/pubmed/33365080 http://dx.doi.org/10.3892/ol.2020.12330

Ejemplares similares

Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2020)

Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection
por: Ma, Bingqi, et al.
Publicado: (2021)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

Decreased expression of acetyl‐CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma
por: Sun, Lin, et al.
Publicado: (2017)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial
por: Hou, Zhenyu, et al.
Publicado: (2020)

Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study
por: Li, Qi, et al.
Publicado: (2022)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis
por: Sha, Meng, et al.
Publicado: (2018)

Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review
por: Zhang, Ning, et al.
Publicado: (2018)

Apatinib is effective for treatment of advanced hepatocellular carcinoma
por: Kong, Yinlong, et al.
Publicado: (2017)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016)

Resection of “down-staged” advanced hepatocellular carcinoma after treatment with the VEGFR2 inhibitor apatinib: five cases report
por: Hou, Zhenyu, et al.
Publicado: (2020)

Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid
por: Wang, Zhiwei, et al.
Publicado: (2021)

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
por: Lan, Xiuwen, et al.
Publicado: (2017)

The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023)

Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
por: Guo, Zhigui, et al.
Publicado: (2016)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma
por: Xin, Hao-Yang, et al.
Publicado: (2023)

HVEM Signalling Promotes Colitis
por: Schaer, Corinne, et al.
Publicado: (2011)

Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma
por: Guo, Kaibo, et al.
Publicado: (2023)

Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases
por: Xun, Xiao-Dong, et al.
Publicado: (2016)

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
por: Demerlé, Clémence, et al.
Publicado: (2023)

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend
por: Chen, Pengyu, et al.
Publicado: (2023)

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
por: Xu, Huan, et al.
Publicado: (2012)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Biomarkers for predicting the prognosis of intrahepatic cholangiocarcinoma: A retrospective single-center study
por: Li, Xueliang, et al.
Publicado: (2023)

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2018)

Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Publicado: (2023)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)

Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection
por: Jeong, Seogsong, et al.
Publicado: (2017)

Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection
por: Jeong, Seogsong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3rdslc5358add6cfjk08dmpc2v